Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Neurobiology of Disease|July 5, 2012
Cholinergic denervation exacerbates amyloid pathology and induces hippocampal atrophy in Tg2576 miceFrancisco J Gil-Bea, Gorka Gerenu, Barbara Aisa, et al.Electrophoresis|October 11, 2011
Analysis of chiral amino acids in cerebrospinal fluid samples linked to different stages of Alzheimer diseaseShorena Samakashvili, Clara Ibáñez, Carolina Simó, et al.Scientific Reports|April 26, 2018
Maternal imprinting on cognition markers of wild type and transgenic Alzheimer's disease model miceMarta Zamarbide, Francisco J Gil-Bea, Paul Bannenberg, et al.Journal of Alzheimer'S Disease : JAD|September 18, 2010
Insulin levels are decreased in the cerebrospinal fluid of women with prodomal Alzheimer's diseaseFrancisco J Gil-Bea, Maite Solas, Alina Solomon, et al.Plos One|February 16, 2021
Corticosteroid-binding-globulin (CBG)-deficient mice show high pY216-GSK3β and phosphorylated-Tau levels in the hippocampusJosé Gulfo, Joana Pérez de San Román, Angelo Ledda, et al.Journal of Alzheimer'S Disease : JAD|February 19, 2010
Altered NCAM expression associated with the cholinergic system in Alzheimer's diseaseBárbara Aisa, Francisco J Gil-Bea, Maite Solas, et al.Journal of Alzheimer'S Disease : JAD|September 23, 2010
HPA axis dysregulation associated to apolipoprotein E4 genotype in Alzheimer's diseaseFrancisco J Gil-Bea, Barbara Aisa, Alina Solomon, et al.Molecular Neurobiology|September 4, 2017
Increased Levels of Brain Adrenomedullin in the Neuropathology of Alzheimer's DiseaseHilda Ferrero, Ignacio M Larrayoz, Eva Martisova, et al.Neurobiology of Aging|July 6, 2005
Involvement of the GABAergic system in depressive symptoms of Alzheimer's diseaseMonica Garcia-Alloza, Shirley W Tsang, Francisco J Gil-Bea, et al.Journal of Chemical Information and Modeling|June 5, 2026
Computational Analysis of ELOVL6 Structure and Inhibition for Rational Drug DesignMarkel G Ibarluzea, Rafael Ramis, Martin Fuentetaja, et al.Pageof 3